Your browser doesn't support javascript.
loading
Genetic association study of promoter variation rs3761549 in the FOXP3 gene of Iranian patients diagnosed with brain tumour.
Moradi, Mehdi; Naeimi, Sirous; Asadzade, Shekofeh; Rahi, Azar.
Afiliação
  • Moradi M; Department of Genetics, Medical Sciences School, Kazerun Branch, Islamic Azad University, Kazerun, Iran.
  • Naeimi S; Department of Genetics, College of Science, Kazerun Branch, Islamic Azad University, Kazerun, Iran.
  • Asadzade S; Department of Genetics, College of Science, Kazerun Branch, Islamic Azad University, Kazerun, Iran.
  • Rahi A; Department of Microbiology, Kazerun Branch, Islamic Azad University, Kazerun, Iran.
J Cell Biochem ; 120(7): 11915-11920, 2019 Jul.
Article em En | MEDLINE | ID: mdl-30802341
ABSTRACT
Forkhead box P3 (FOXP3) gene (Gene ID 50943, Xp11.23) is an X-linked gene that encodes FOXP3 protein, an essential transcription factor in CD4+ CD25+ FOXP3 regulatory T (Treg) cells. FOXP3 mutation has been linked with the pathogenesis of several tumours; however, little is known about the role of single-nucleotide polymorphism (SNP) in its promoter region and its correlation with brain tumour. In the present study, we have investigated the association between SNPs in the promoter region of FOXP3 gene, a promoter SNP, -2383 C/T (rs3761549) with susceptibility to brain cancer in a population of Iran. The distribution of case, control, age and sex was balanced and with rs3761549 C/T allele frequencies distribution also falling in Hardy-Weinberg equilibrium (P = 0.053 and 0.062). The allele C of rs3761549 is lower in the brain tumour cases when compared with the controls (364 vs 392, P = 0.005). The frequency of combined T variant genotype (TT + CT) was significantly higher in the brain cancer cases compared with the controls (28 vs 8, P = 0.001), which was consistent with the T allele distribution. When we used the CC genotype as a reference, we found that both CT and TT genotypes were associated with a higher risk of developing brain tumour (odds ratio [OR], 0.3583; 95% confidence interval [CI], 0.164-0.8197 and OR, 0; 95% CI, 0-0.4118, respectively).
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Risk_factors_studies Idioma: En Revista: J Cell Biochem Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Irã

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Risk_factors_studies Idioma: En Revista: J Cell Biochem Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Irã